S. V. Maksimova

S. V. Maksimova

Auto-generated profile, based on publicly available information

S. V. Maksimova

Novosibirsk State Medical University; Research Institute for Internal and Preventive Medicine — Branch of the Federal Research Center Institute of Cytology and Genetics

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2020 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
Vladimir Nikolaevich MaksimovVladimir Nikolaevich Maksimov
Vladimir Nikolaevich Maksimov
DIDinara Ivanoshchuk
Dinara Ivanoshchuk
POPavel Sergeevich Orlov
Pavel Sergeevich Orlov
AIA. A. Ivanova
A. A. Ivanova
SMSofia Malyutina
Sofia Malyutina
MVMikhail Voevoda
Mikhail Voevoda
Aim. To search for causal mutations in candidate genes responsible for the development of sudden cardiac death (SCD) in men who died under the age of 45. Material and methods. The SCD group (n=37) was formed using the criteria the World Health Organization and the European Society of Cardiology. Autopsy material was collected from men who died suddenly outside medical institutions and underwent forensic medical examination according to the standard protocol. Autopsy revealed no morphological changes that could explain sudden death. The mean age was 32,4±6,4 years. Genomic DNA was isolated from myocardial tissue using phenol-chloroform extraction. Clinical exome sequencing was performed. At first, we analyzed the results of sequencing of 24 genes, mutations in which lead to cardiovascular diseases associated with an increased risk of SCD: KCNQ1, KCNH2, SCN5A, AKAP9, ANK2, CACNA1C, CALM1, CALM2, CAV3, KCNE1, KNCJNE2, KCNE2, SCN4B, SNTA1, MYH2, APOB, KCNA5, TGFB3, NEB , PDX1, FLNC, PLEC, KCND3. Results. Of 37 samples, we revealed 13 probable pathogenic missense mutations in 9 samples (24,3%). Of 13 probable pathogenic variants, 5 were new. Conclusion. This pilot study provides following conclusions: it is necessary to continue molecular autopsy research in Russia; to increase the effectiveness of detecting causal mutations, it is necessary to reduce the age of patients with SCD included in the study; studying the families of deceased; cooperation of experienced specialists — forensic pathologist, laboratory geneticist, cardiologist.

15 March 2024 in Ateroscleroz
Verified
Journal Article
Open access
PDF file
VKV. A. Kozik
V. A. Kozik
LSL. A. Shpagina
L. A. Shpagina
ISIlya Shpagin
Ilya Shpagin
SMS. V. Maksimova
S. V. Maksimova
NLNatalya Lozhkina
Natalya Lozhkina
VMV. N. Maksimov
V. N. Maksimov
Introduction. Cardiovascular diseases (СVD) rank first in terms of morbidity and mortality not only in the Russian Federation but throughout the world. Since the end of 2019 a pandemic of Severe Acute Respiratory Syndrome (SARS) or new coronavirus infection (NCI) has spread throughout the world, which contributed to the development and course of CVD. Therefore, genetic markers began to be considered as factors potentially influencing CVD, its development and severity. Objective: To evaluate the association of the nucleotide sequence variant rs12329760 of the TMPRSS2 gene with acute coronary syndrome in patients who have had a new coronavirus infection.Material and methods. The study included 100 patients (women – 50, men – 50) with ACS and previous NCI, who were selected on the basis of a positive PCR test for the presence of SARS-CoV-2 in the anamnesis, hospitalized at the regional vascular center No. 7 of the City Clinical Hospital No. 2 of the city of Novosibirsk. Women age was 59.5 ± 7.2 years, men age was 53.5 ± 9.3 years. The diagnosis of ACS was established according to a set of criteria proposed and established by the Russian Society of Cardiology and in accordance with the updated clinical recommendations of the Ministry of Health of the Russian Federation of 2020. Patients underwent clinical and instrumental examination, coronary angiography with possible stenting, as provided for in the standards of medical care and clinical guidelines. The nucleotide sequence variant rs12329760 of the TMPSS2 gene was determined in patients using PCR with further analysis of restriction fragment length polymorphism. The comparison group consisted of 200 patients with ACS without previous NCI (no positive PCR test, no positive antibodies).Results. Carriage of CC, СТ, TT, genotype variants of the nucleotide sequence rs12329760 of the TMPSS2 gene are not associated with an increased risk of developing ACS in patients with previous NCI. When comparing the frequencies of the rs12329760 genotypes of the TMPSS2 gene in groups with ACS with NCI and ACS without NCI, no statistically significant differences were obtained. In the group with ACS with NCI, carriage of the homozygous genotype was more common (p = 0.011).Conclusions. Variants of the nucleotide sequence rs12329760 of the TMPSS2 gene are not associated with ACS with previous NCI.

13 May 2024 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
VKV. A. Kozik
V. A. Kozik
LSL. A. Shpagina
L. A. Shpagina
ISIlya Shpagin
Ilya Shpagin
SMS. V. Minnikh
S. V. Minnikh
NLNatalya Lozhkina
Natalya Lozhkina
Vladimir Nikolaevich MaksimovVladimir Nikolaevich Maksimov
Vladimir Nikolaevich Maksimov
Aim. To assess the rs2285666 nucleotide sequence of the angiotensin-converting enzyme 2 (ACE2) gene and its association with acute coronary syndrome (ACS) in patients after coronavirus disease 2019 (COVID-19).Material and methods. The study included 100 patients after COVID-19, including 50 men and 50 women, hospitalized with a diagnosis of ACS. The diagnosis of COVID-19 in all 100 patients was confirmed by a positive polymerase chain reaction (PCR) smear. All patients underwent percutaneous transluminal coronary angioplasty with stenting, standard clinical and paraclinical examination, and genetic testing of the rs2285666 ACE2 gene by PCR followed by restriction fragment length polymorphism analysis. The comparison group consisted of 200 patients with ACS after COVID-19, confirmed by a PCR smear or antibody titer.Results. Statistically significant differences were obtained for the AA genotype, carriage of which among male patients with ACS after COVID-19 was 2,5 times less common than in men in the control group (OR =0,391, 95% CI: 0,167-0,917; p=0,028). On the other hand, carriage of the rs2285666 GA genotype of the ACE2 gene is not associated with an increased risk of ACS in women after COVID-19. There were no significant differences in genotype frequencies in the group of women and in the general group (without division by sex).Conclusion. The data obtained may indicate a protective role of the rs2285666 AA genotype of the ACE2 gene for males regarding ACS development after COVID-19. These results are the first steps towards building a prognostic model to estimate the ACS risk in patients after COVID-19, which will reduce morbidity and mortality for this group of patients.

7 January 2021 in Bulletin of Siberian Medicine
Verified
Journal Article
Open access
PDF file
AIA. A. Ivanova
A. A. Ivanova
AGA. A. Gurazheva
A. A. Gurazheva
EAE. I. Akinshina
E. I. Akinshina
SMS. V. Maksimova
S. V. Maksimova
SMSofia Malyutina
Sofia Malyutina
Vladimir Nikolaevich MaksimovVladimir Nikolaevich Maksimov
Vladimir Nikolaevich Maksimov
Метилирование промотора гена ABCA1 и внезапная сердечная смерть

18 September 2025 in Doctor.Ru
Verified
Journal Article
Open access
Vladimir Nikolaevich MaksimovVladimir Nikolaevich Maksimov
Vladimir Nikolaevich Maksimov
RNRussian Federation Novosibirsk
Russian Federation Novosibirsk
SMS.V. Michin
S.V. Michin
YIYu.V. Ivanova
Yu.V. Ivanova
EMElizaveta Melnikova
Elizaveta Melnikova
SMSofia Malyutina
Sofia Malyutina
Aim. To study the association of rs9939609 of the FTO gene with various obesity phenotypes, its individual parameters, and some risk factors in a sample of women Design. Cross-sectional cohort study. Materials and methods. The study was conducted on the basis of the population sample of the HAPIEE project, the age of the participants was — 45–69 years (n = 1036). Groups of women were formed, selected by body mass index (BMI) using the criteria of the World Health Organization. DNA was isolated from blood using the phenol-chloroform extraction method. Genotyping of the rs9939609 gene FTO was performed using polymerase chain reaction (PCR) with restriction fragment length polymorphism and real-time PCR (TaqMan probes). The frequency of genotypes in groups with different BMI, with different body roundness indexes (BRI), waist and hip circumference; with morbid obesity (MO) and abdominal obesity (AO) was analyzed. Results. When comparing the frequencies of the A allele (AA and AT genotypes) and the TT genotype in groups with different BMIs, significant differences were obtained (p = 0.007). The highest frequency of the TT genotype (38.5%) was in the group of women with a BMI of 18.5 to 24.9 kg/m2, the lowest (23.5%) — with a BMI of 35 to 39.9 kg/m2. In this group, the AA genotype was most common. The frequency of carriage of the AT genotype increased nonlinearly with increasing BMI. The statistical significance of differences in BMI between carriers of different genotypes according to the Kruskal — Wallis — test is less than 0.001. Significant differences were also observed in waist (p = 0.001) and hip (p < 0.001) circumferences — the smallest in carriers of the TT genotype. In univariate logistic regression analysis with age-adjusted adjustment, the odds ratio (OR) of having MO in the AA genotype — 1.80 (95% confidence interval (CI): 1.09–2.95; p = 0.021), in the AT genotype — 1.82 (95% CI: 1.23–2.68; p = 0.002), and in the TT genotype — 0.56 (95% CI: 0.39–0.81; p = 0.002). In the univariate logistic regression analysis with age-adjusted analysis, the significance of the TT genotype carriage as a conditionally protective factor in relation to the development of MO (OR = 0.56; 95% CI: 0.34–0.91; p = 0.021) and AO (OR = 0.65; 95% CI: 0.45–0.94; p = 0.023) was preserved, as was the increased probability of AO in carriers of the AT genotype (OR = 1.53; 95% CI: 1.15–2.02; p = 0.003) and AA genotype (OR = 1.54; 95% CI: 1.06–2.23; p = 0.023). Conclusion. Carriage of the A allele of rs9939609 of the FTO gene is an important factor associated with various obesity phenotypes in women. Due to the diversity of factors associated with obesity, it is necessary to continue research in this area to develop effective personalized preventive and therapeutic strategies. Keywords: nucleotide sequence variant, obesity, morbid, abdominal, body roundness index, FTO gene, rs9939609, body mass index

4 July 2024 in Ateroscleroz
Verified
Journal Article
Open access
PDF file
Vladimir Nikolaevich MaksimovVladimir Nikolaevich Maksimov
Vladimir Nikolaevich Maksimov
SMS. V. Minnikh
S. V. Minnikh
AIA. A. Ivanova
A. A. Ivanova
Cardiovascular diseases are the leading cause of non-violent deaths in the world. Criteria for the formation of high-risk groups are necessary for primary prevention of disease development. This was the reason for research on the development of riskmeters. A brief description of the history of the creation of CHD riskmeters. The review provides a description of the current challenges in assessing individual risk for CHD. The main approaches to the creation of riskmeters have not changed significantly for several decades. The increase in the size of study groups and the number of molecular genetic markers undoubtedly give certain results. However, in order to move from the population level to the individual level, it is necessary to take into account many more factors in the assessment. That is, it is necessary to learn how to analyze the most complex set of data of one person (genome, transcriptome, proteome, and maybe even microbiome) not only with a deep understanding of the mechanisms of its functioning (from conception to death), but also possible disorders, based on the available features. And for this purpose it is necessary to rely not only and not so much on statistical data, but on maximally similar sets of individual data (first of all, relatives). It seems that similarity should be evaluated by an artificial intelligence system trained on a colossal array of individual data.